Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can Effective Interventions Reduce Tooth Decay in Young Children?
Research & Development Can Effective Interventions Reduce Tooth Decay in Young Children?

Tooth decay among young children is a significant public health concern in England, affecting up to 50% of 5-year-olds and often leading to severe pain and dental extractions under general anesthetic. Researchers at the University of Manchester, in collaboration with Manchester's Oral Health

Revolutionizing Beauty and Health: NihonChojyu Clinic Expands to Thailand
Research & Development Revolutionizing Beauty and Health: NihonChojyu Clinic Expands to Thailand

The launch of an advanced cell restoration treatment in Thailand marks a significant milestone in the Thai-Japan partnership. NihonChojyu Clinic, established by Dr. Masatoshi Egoshi, is at the forefront of this healthcare innovation, emphasizing the restoration of health and beauty from the

Is Cetuximab More Effective Than Durvalumab for Head and Neck Cancer?
Research & Development Is Cetuximab More Effective Than Durvalumab for Head and Neck Cancer?

Head and neck cancers rank as the seventh most common type of cancer globally, significantly impacting smokers, drinkers, and individuals with HPV infections. Cisplatin, a standard chemotherapy drug, coupled with radiation therapy, remains the gold standard for treating these cancers. However, over

How Does TRISCO Revolutionize 3D RNA Analysis in Intact Mouse Brains?
Tech & Innovation How Does TRISCO Revolutionize 3D RNA Analysis in Intact Mouse Brains?

In a revolutionary breakthrough, researchers at Karolinska Institutet and Karolinska University Hospital have developed an innovative microscopy technique called TRISCO, which allows for intricate three-dimensional (3D) RNA analysis at cellular resolution in whole, intact mouse brains. This

Gestational Diabetes Does Not Predispose Infants to Obesity: Study Shows
Research & Development Gestational Diabetes Does Not Predispose Infants to Obesity: Study Shows

A groundbreaking study led by researchers from The University of Texas at Austin and Harvard Medical School has challenged the prevailing assumption that infants exposed to gestational diabetes mellitus (GDM) are at an automatically higher risk of developing childhood obesity. Published in the

Little Journey Secures £6M Funding to Revolutionize Pediatric Care Globally
Tech & Innovation Little Journey Secures £6M Funding to Revolutionize Pediatric Care Globally

In a significant move towards revolutionizing pediatric care, Little Journey, a digital health startup, has secured £6 million in Series A funding. This development aims to enhance its personalized psychological support platform for children and families interacting with healthcare systems. As a

How Far Will Pet Owners Go to Save Their Beloved Animals?
Research & Development How Far Will Pet Owners Go to Save Their Beloved Animals?

Stéphanie Gauvin and Tim MacIsaac, a devoted couple hailing from Nova Scotia, have embarked on a challenging and emotional journey to save their five-year-old golden doodle, Lucy, diagnosed with T-cell lymphoma. In their quest to find the best possible treatment for Lucy, they have encountered

New Study Links Caudate Dopamine Preservation to Parkinson's Tremor
Research & Development New Study Links Caudate Dopamine Preservation to Parkinson's Tremor

The groundbreaking study conducted by researchers from the Champalimaud Foundation sheds new light on the complex and previously misunderstood relationship between dopamine levels in the brain and rest tremor in patients with Parkinson's Disease (PD). Published in npj Parkinson's Disease,

Impact of Hormone Therapy and Puberty Blockers on Transgender Skeletons
Research & Development Impact of Hormone Therapy and Puberty Blockers on Transgender Skeletons

In the evolving landscape of transgender healthcare, a profound area of research delves into how hormone therapy and puberty blockers affect skeletal dimensions in transgender individuals. Presented at the 62nd Annual European Society for Paediatric Endocrinology Meeting in Liverpool,

Transformative Potential of GHRH in Treating Various Chronic Diseases
Research & Development Transformative Potential of GHRH in Treating Various Chronic Diseases

Growth hormone-releasing hormone (GHRH), also known as somatoliberin, has emerged as a significant focus in medical research due to its extensive biological activities and therapeutic potential. GHRH, a family of hypothalamic peptide hormones, plays a crucial role in stimulating and modulating the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later